Recombinant Human Neuromedin-K receptor (TACR3)

What is TACR3 and what are its structural characteristics?

TACR3 (Tachykinin Receptor 3) belongs to the tachykinin receptor family of G protein-coupled receptors (GPCRs) within the rhodopsin subfamily . It functions by binding to its high-affinity ligand, neurokinin B (NKB) .

Structurally, TACR3 is characterized by:

• Seven hydrophobic transmembrane domains

• Association with G proteins that activate phosphatidylinositol-calcium second messenger systems

• A protein sequence of approximately 300-302 amino acids (species dependent)

Methodology for structural characterization:

• Bioinformatic analysis using tools such as TMHMM Server v. 2.0 for transmembrane domain prediction

• Cloning and sequence analysis with BioEdit software

• Phylogenetic analysis using MEGA 6.0 with the neighbor-joining method

Where is TACR3 primarily expressed in mammalian systems?

TACR3 shows distinct expression patterns across various tissues:

Brain regions with high TACR3 expression:

• Hippocampus, particularly the ventral region

• Hypothalamus

• Amygdala and cortex

• Midbrain structures

• Substantia nigra

Peripheral expression:

• Reproductive tissues

• Evidence of expression in oral squamous cell carcinoma

Methods for detecting TACR3 expression:

• In situ hybridization for mRNA localization

• Immunohistochemistry for protein localization

• RT-PCR for quantitative expression analysis

• Western blotting for protein quantification

What is the relationship between TACR3 and reproductive function?

TACR3 plays a critical role in reproductive physiology:

Reproductive phenotypes associated with TACR3 dysfunction:

• Hypogonadotropic hypogonadism with or without anosmia

• Delayed or absent sexual maturation

• Subfertility in animal models

Mechanistic data:

• Mutations in TACR3 are associated with GnRH deficiency

• TACR3 modulates gonadotropin release through its action on Kisspeptin-1 neurons in the hypothalamus

• In Tacr3-/- mice, females showed:

  • Abnormal estrous cyclicity (86.8% time in diestrus vs. 52.5% in wild-type)

  • Reduced uterine weight

  • Absence of corpora lutea in approximately 50% of females

• In Tacr3-/- mice, males showed:

  • Smaller testes (159 ± 11 mg vs. 208 ± 11 mg in wild-type)

  • Lower FSH levels (9.9 ± 0.7 ng/ml vs. 28.9 ± 2.0 ng/ml in wild-type)

Research approaches:

• Knockout mouse models

• Histological analysis of reproductive tissues

• Hormone assays (FSH, LH, testosterone)

• Fertility testing through breeding experiments

What methodologies are most effective for studying TACR3-mediated neuronal signaling?

The study of TACR3-mediated neuronal signaling requires specialized techniques:

Electrophysiological approaches:

• Multielectrode arrays to measure neuronal cross-correlation and firing patterns

• Recording of long-term potentiation (LTP) in hippocampal slices

Molecular signaling assessment:

• Analysis of CaMKII activation status

• AMPA receptor phosphorylation measurement

• G protein coupling analysis

Morphological analysis:

• Spine density quantification using microscopy

• Dendritic arborization measurements

Pharmacological tools:

• Osanetant (TACR3 antagonist) for in vivo and in vitro studies

• Administration protocols:

  • Intraperitoneal injection: 5 mg/kg dose

  • Intracerebroventricular delivery: 100 nM via osmotic minipumps

  • In vitro application to neuronal cultures

How does TACR3 interact with testosterone and what are the implications for anxiety regulation?

Recent research has revealed a complex relationship between TACR3, testosterone levels, and anxiety:

Key findings:

• Male rats with high anxiety show reduced TACR3 expression in the ventral hippocampus

• TACR3 expression increases substantially during male sexual development, coinciding with elevated testosterone and reduced anxiety

• Deficient TACR3 activity leads to lower serum testosterone levels

• Testosterone treatment increases TACR3 expression in the hippocampus

Experimental evidence:

• Testosterone propionate treatment (5 mg/kg/day for 5 days) significantly alters hippocampal TACR3 expression

• TACR3 inhibition through osanetant affects spine density and synaptic connectivity

• The firing pattern in response to LTP induction is inadequate in neurons expressing defective TACR3, which can be corrected with testosterone treatment

Methodological approaches:

• Behavioral testing for anxiety assessment

• Serum testosterone measurements following treatments:

  • Testosterone Parameter Assay Kit (R&D Systems)

  • Competitive Immunoassay using direct chemiluminescent Technology

• Western blot analysis of TACR3 expression

What are the species-specific differences in TACR3 structure and function?

TACR3 shows notable evolutionary conservation but with important species-specific variations:

Comparative structural features:

• In Japanese eel (Anguilla japonica):

  • Two tac3 genes (tac3a, tac3b) encode different NKB peptides

  • A single tacr3 gene with a premature stop codon

  • This mutation appears conserved across multiple eel species

• In mammals:

  • Human TACR3: Located on chromosome 4q24, contains 5 exons

  • Rat Tacr3: Shows expression patterns that fluctuate with hormonal status

  • Mouse Tacr3: Knockout models show subfertility but not complete infertility

Functional differences:

• Humans with TACR3 mutations exhibit complete GnRH deficiency and hypogonadism

• Tacr3-/- mice show milder phenotypes with subfertility rather than infertility

• This phenotypic discordance between species suggests differential compensation mechanisms

Research approaches:

• Cross-species sequence alignment

• Phylogenetic analysis

• Comparative phenotyping of knockout/mutant models

• RACE-PCR for species-specific gene cloning

How does TACR3 affect synaptic plasticity and what are the underlying mechanisms?

TACR3 plays a significant role in regulating synaptic function:

Effects on synaptic structures:

• TACR3 inhibition is associated with:

  • Increased spine density

  • Enhanced AMPA receptor phosphorylation

  • Stronger cross-correlation of neuronal firing

• Functional TACR3 expression in spines results in:

  • Spine shrinkage and pruning

  • Regulation of long-term potentiation (LTP)

Molecular pathways:

• TACR3 modulation significantly influences CaMKII activation

• TACR3 is expressed in presynaptic compartments and affects synaptic activity

• TACR3 dysfunction impairs LTP in the dentate gyrus

Methodological considerations:

• Electrophysiological recordings using multielectrode arrays

• Analysis of synaptic protein phosphorylation status

• Morphological analysis of dendritic spines

• LTP induction protocols for functional assessment

What strategies should be considered when designing TACR3-targeted therapeutic interventions?

Developing interventions targeting TACR3 requires consideration of multiple factors:

Therapeutic potential:

• Anxiety disorders: TACR3 modulation affects anxiety-related behaviors

• Reproductive disorders: Potential for treating hypogonadotropic hypogonadism

• Neurological conditions: Possible applications in Alzheimer's and Parkinson's diseases

Intervention approaches:

• TACR3 antagonists (e.g., osanetant)

• Testosterone supplementation to modulate TACR3 expression or compensate for its dysfunction

• Targeted delivery to specific brain regions (e.g., ventral hippocampus)

Considerations for experimental design:

• Sex differences in TACR3 expression and function

• Age-dependent effects (developmental vs. adult)

• Potential off-target effects on other tachykinin receptors

• Route of administration (peripheral vs. central)

Assessment methods:

• Behavioral testing for anxiety and reproductive parameters

• Hormone level monitoring

• Electrophysiological recordings for neural activity

• Histological and molecular analysis of target tissues